<img title="heart attack" src="https://images.mid-day.com/images/2018/feb/Farmer-dies.jpg" alt="heart attack" width="670" height="447" />Representational Image
A commonly used drug for treating osteoporosis or bone pain may also help reduce the risk of death by cardiovascular, heart attack and stroke, according to a study.
The report, published in Journal of Bone and Mineral Research, showed that the drug Alendronate could lower the risk of cardiovascular diseases by 67 per cent and heart attacks by 45 per cent within a year.
Intake of the drug also reduced the risk of stroke by 18 per cent within five years and 17 per cent within 10 years.
"Our findings show that Alendronate is potentially cardioprotective in hip fracture patients," said Ching-Lung Cheung, from the University of Hong Kong.
"Physicians should consider prescribing Alendronate or other similar drugs to patients with hip fracture and patients should also have good compliance with Alendronate treatment, as this is not only good for your bones but also your heart," Cheung added.
Alendronate belongs to a class of drugs called bisphosphonates and works by preventing bone breakdown and increasing bone density.
It is used for osteoporosis, osteogenesis imperfecta, and several other bone diseases.
The researchers collected data from 34,991 patients, diagnosed with a hip fracture in 2005. Out of these 4,602 patients received osteoporosis treatment during follow up.
Due to excess cardiovascular adverse events, there is a worldwide crisis in the current treatment of osteoporosis with drug romosozumab.
In 2017, the US Food and Drug Administration (FDA) had rejected romosozumab and requested more data before reaching a decision.
The study, thus, has significant implications in the clinical trial design of anti-osteoporosis medications, the researchers said.
Catch up on all the latest <a title="mid-day news" href="https://www.mid-day.com/news" target="_blank">Crime, National, International and Hatke news</a> here. Also, download the new mid-day <a title="mid-day android app " href="https://goo.gl/8Xlcvr" target="_blank">Android</a> and <a title="mid-day iOS app" href="https://goo.gl/KQziH4" target="_blank">iOS</a> apps to get latest updates
<div id=":74.co" class="JL">
<div id=":78.ma" class="Mu SP" style="text-align: justify;" data-tooltip="February 20, 2018 at 6:39:14 PM UTC+5:30">This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.</div>
</div>

Game Review: Remastered version of Assassin's Creed: Rogue is ancient and boring

The report, published in Journal of Bone and Mineral Research, showed that the drug Alendronate could lower the risk of cardiovascular diseases by 67 per cent and heart attacks by 45 per cent within a year

Osteoporosis drug may help reduce heart diseases

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast

Home / Lifestyle / Health & Fitness / Article / Osteoporosis drug may help reduce heart diseases

Osteoporosis drug may help reduce heart diseases

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast